# Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

> **NCT02531880** · PHASE1 · RECRUITING · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 40 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Mangafodipir

## Key facts

- **NCT ID:** NCT02531880
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-19
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02531880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02531880, "Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02531880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*